116
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief as an Adjunctive Therapy to Antibiotic Treatment of Acute Respiratory Infections

, MD, , MD & , MD
Pages 53-59 | Published online: 30 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (16)

Gene Clark, Dominic A. Fitzgerald & Bruce K. Rubin. (2023) Cough medicines for children- time for a reality check. Paediatric Respiratory Reviews.
Crossref
Ghazal Rouhani, Zehra Ceren Ertekin & Erdal Dinç. (2022) A Chemometric Strategy in the Development of a RP-UPLC Method for the Quantitative Resolution of a Two-Component Syrup Formulation. Journal of Chromatographic Science 60:10, pages 937-945.
Crossref
Wen-Ba Wang, Jing-Tao Li, Yi Hui, Jie Shi, Xu-Yan Wang & Shu-Guang Yan. (2022) Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway. Chinese Medicine 17:1.
Crossref
Jin Yoon, Hyun Jee Kim, Jang-Ho Seo & Hye-Ryun Kang. (2022) A Case Report of Guaifenesin-Induced Anaphylaxis. Journal of Pharmacoepidemiology and Risk Management 14:2, pages 169-172.
Crossref
Tomasz Blicharski, Katarzyna Swiader, Anna Serefko, Sylwia Kulczycka-Mamona, Michal Kolodziejczyk & Aleksandra Szopa. (2019) Challenges in technology of bilayer and multi-layer tablets: a mini-review. Current Issues in Pharmacy and Medical Sciences 32:4, pages 229-235.
Crossref
Edward J. Septimus, Helmut H. Albrecht, Gail Solomon, Tim Shea & Eric P. Guenin. (2017) Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study. Current Therapeutic Research 84, pages 54-61.
Crossref
Cheol Moon & Euichaul Oh. (2016) Rationale and strategies for formulation development of oral fixed dose combination drug products. Journal of Pharmaceutical Investigation 46:7, pages 615-631.
Crossref
Bruce K. Rubin, Kostas N. Priftis, H. Joel Schmidt & Markus O. Henke. (2014) Secretory Hyperresponsiveness and Pulmonary Mucus Hypersecretion. Chest 146:2, pages 496-507.
Crossref
Admassu Abebe, Ilgaz Akseli, Omar Sprockel, Niranjan Kottala & Alberto M. Cuitiño. (2014) Review of bilayer tablet technology. International Journal of Pharmaceutics 461:1-2, pages 549-558.
Crossref
Lineau VilsonJrJr & Joel S. Owen. (2013) Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended‐Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval. Clinical Pharmacology in Drug Development 2:1, pages 25-32.
Crossref
Niranjan Kottala, Admassu Abebe, Omar Sprockel, James Bergum, Faranak Nikfar & Alberto M. Cuitiño. (2012) Evaluation of the Performance Characteristics of Bilayer Tablets: Part II. Impact of Environmental Conditions on the Strength of Bilayer Tablets. AAPS PharmSciTech 13:4, pages 1190-1196.
Crossref
Niranjan Kottala, Admassu Abebe, Omar Sprockel, James Bergum, Faranak Nikfar & Alberto M. Cuitiño. (2012) Evaluation of the Performance Characteristics of Bilayer Tablets: Part I. Impact of Material Properties and Process Parameters on the Strength of Bilayer Tablets. AAPS PharmSciTech 13:4, pages 1236-1242.
Crossref
Gary N. Gross. (2011) What are the Primary Clinical Symptoms of Rhinitis and What Causes Them?. Immunology and Allergy Clinics of North America 31:3, pages 469-480.
Crossref
Fridrun Podczeck & Emad Al-Muti. (2010) The tensile strength of bilayered tablets made from different grades of microcrystalline cellulose. European Journal of Pharmaceutical Sciences 41:3-4, pages 483-488.
Crossref
Sivakumar R. Vaithiyalingam & Vilayat A. Sayeed. (2010) Critical factors in manufacturing multi-layer tablets—Assessing material attributes, in-process controls, manufacturing process and product performance. International Journal of Pharmaceutics 398:1-2, pages 9-13.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.